£44.15

This is the most expensive it has ever been. Walk away.

£44 today · previous high £44 · all-time low £43

MDPI AG Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 60 days · 60 data points (no recent data)

Historical
Generating forecast…
£44.15 £43.41 £43.57 £43.73 £43.90 £44.06 £44.22 28 July 2026 11 August 2026 26 August 2026 10 September 2026 25 September 2026
View at Amazon ↗

Price data last checked 31 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 60 days • 2 price levels

Days at Price
Current Price
14 days 46 days · current 0 12 23 35 46 £43 £44 Days at Price

Price Analysis

Most common price: £44 (46 days, 76.7%)

Price range: £43 - £44

Price levels: 2 different prices over 60 days

Description

For the past 40 years, metal-based drugs have been widely used for the treatment of cancer. Cisplatin and follow-up drugs carboplatin (ParaplatinTM) and oxaliplatin (EloxatinTM) have been the gold standard for metallodrugs in clinical settings as antineoplastic agents. While effective, these drugs (either alone or in combination therapy) have faced a number of clinical challenges resulting from their limited spectrum of activity, high toxicity leading to significant side effects, resistance, poor water solubility, low bioavailability and short circulating time. In the past 10 years, various unconventional non-platinum metal-based agents have emerged as a potential alternative for cancer treatment. These compounds are highly effective and selective in cancers resistant to cisplatin and other chemotherapeutic agents. Research in this area has recently exploded with a relevant number of patents and clinical trials, in addition to reports in scientific journals. Furthermore, in parallel to the synthesis of coordination and organometallic compounds comprising many different metals and unconventional platinum-based derivatives, researchers are focused on optimizing mechanistic and pharmacological features of promising drug candidates. This Special Issue aims to highlight the latest advances in anticancer metallodrugs with a focus on unconventional anticancer agents, as well as novel activation, targeting and delivery strategies aimed at improving their pharmacological profile.

Product Specifications

Brand
MDPI AG
Format
paperback
Domain
Amazon UK
Release Date
30 September 2019
Listed Since
02 October 2019

Barcode

No barcode data available

Similar Products You Might Like

Metal-based Anticancer Agents: Volume 14 (Metallobiology)
97% match

Metal-based Anticancer Agents: Volume 14 (Metallobiology)

Royal Society of Chemistry

£135.54 13 Oct 2026
96% match

Heterometallic Complexes as Anticancer Agents

Wiley

£140.00 01 Oct 2026
Targeted Metallo-Drugs: Design, Development, and Modes of Action (Metal Ions in Life Sciences Series)
96% match

Targeted Metallo-Drugs: Design, Development, and Modes of Action (Metal Ions in Life Sciences Series)

CRC Press

£104.90 26 Sep 2026
Essential and Non-essential Metals: Carcinogenesis, Prevention and Cancer Therapeutics (Molecular and Integrative Toxicology)
96% match

Essential and Non-essential Metals: Carcinogenesis, Prevention and Cancer Therapeutics (Molecular and Integrative Toxicology)

Humana

£172.11 24 Sep 2026
Targeting Cancer Cell Signaling by Natural Products: An Insight into the Anticancer Potentials of Natural Products
96% match

Targeting Cancer Cell Signaling by Natural Products: An Insight into the Anticancer Potentials of Natural Products

LAP Lambert Academic Publishing

£47.00 06 Oct 2026
5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents: Synthesis of New Substituted Anticancer Agent Part I
95% match

5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents: Synthesis of New Substituted Anticancer Agent Part I

LAP Lambert Academic Publishing

£48.00 13 Oct 2026
Cancer Chemotherapy
95% match

Cancer Chemotherapy

Butterworth-Heinemann

£43.99 04 Sep 2026
Metal-Containing Molecules and Nanomaterials: From Diagnosis to Therapy (Metal Ions in Life Sciences Series)
95% match

Metal-Containing Molecules and Nanomaterials: From Diagnosis to Therapy (Metal Ions in Life Sciences Series)

CRC Press

£138.44 23 Sep 2026
Cancer Drug Discovery: Fascinating Anecdotes of Oncology Medicine (Pillars of Progress in Drug Discovery)
95% match

Cancer Drug Discovery: Fascinating Anecdotes of Oncology Medicine (Pillars of Progress in Drug Discovery)

CRC Press

£183.52 21 Aug 2026
Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies (Novel approaches to overcome cancer resistance to conventional therapies)
95% match

Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£145.99 23 Sep 2026
Modeling Prevalent Cancers: Understanding and Innovating Therapeutic Approaches
95% match

Modeling Prevalent Cancers: Understanding and Innovating Therapeutic Approaches

CRC Press

£119.35 18 Sep 2026
Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine
95% match

Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine

Elsevier

£152.99 02 Oct 2026
Cancer Treatment: Conventional and Innovative Approaches
95% match

Cancer Treatment: Conventional and Innovative Approaches

IntechOpen

£147.51 02 Oct 2026
Principles of Anticancer Drug Development - Clinical Trial Guide
95% match

Principles of Anticancer Drug Development - Clinical Trial Guide

Humana

£108.75 09 Oct 2026
Unique Aspects of Anti-cancer Drug Development
95% match

Unique Aspects of Anti-cancer Drug Development

IntechOpen

£95.89 24 Sep 2026
Pharmacological Approaches in Cancer Treatment: A Comprehensive Guide
95% match

Pharmacological Approaches in Cancer Treatment: A Comprehensive Guide

Elsevier

£137.99 02 Oct 2026
TOXIC METAL CHELATION: STRATEGIES TO DESIGN PEPTIDE CHELATORS FOR CARCINOGENIC METALS
95% match

TOXIC METAL CHELATION: STRATEGIES TO DESIGN PEPTIDE CHELATORS FOR CARCINOGENIC METALS

LAP Lambert Academic Publishing

£61.00 23 Sep 2026
Synthesis of New 4-Quinolones of Expected Anticancer Activity: Synthesis, Drug Design and Biological Assay
95% match

Synthesis of New 4-Quinolones of Expected Anticancer Activity: Synthesis, Drug Design and Biological Assay

LAP Lambert Academic Publishing

£43.00 25 Sep 2026
Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America: Volume 38-4 (The Clinics: Internal Medicine, Volume 38-4)
95% match

Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America: Volume 38-4 (The Clinics: Internal Medicine, Volume 38-4)

Elsevier

£77.49 17 Sep 2026
Natural Products and Nano-Formulations in Cancer Chemoprevention (Advances in Bionanotechnology)
95% match

Natural Products and Nano-Formulations in Cancer Chemoprevention (Advances in Bionanotechnology)

CRC Press

£61.47 11 Sep 2026
Natural Products and Nano-Formulations in Cancer Chemoprevention (Advances in Bionanotechnology)
95% match

Natural Products and Nano-Formulations in Cancer Chemoprevention (Advances in Bionanotechnology)

CRC Press

£108.00 29 Aug 2026
Focus on Cancer Research
95% match

Focus on Cancer Research

Brand: Nova Science Pub Inc

£12.34 24 Sep 2026
Gefahrensignale: Chemotherapiewaffen zur Stärkung der Anti-Tumor-Immunität
95% match

Gefahrensignale: Chemotherapiewaffen zur Stärkung der Anti-Tumor-Immunität

£48.00 15 Oct 2026
Anticancer Drugs 2021
95% match

Anticancer Drugs 2021

£84.18 14 Oct 2026